MSE News and Events
Institute News
Rensselaer Polytechnic Institute has established the Office of Strategic Alliances and Translation, a new area within the university that incorporates a number of key translational activities at RPI, including intellectual property and technology licensing, large-scale corporate partnerships, initiation and growth of start-up ventures, and translational campuses, including the Rensselaer Technology Park, as well as translational activities in New York City.
What if microgravity holds the key to preventing the overheating of advanced electronics? That’s one idea behind an International Space Station (ISS) National Laboratory-sponsored investigation that recently launched to station on Northrop Grumman’s 19th Commercial Resupply Services mission (NG-19). This week, the ISS crew is working on the experiment, which aims to improve the efficiency of heat transfer devices used in various technologies, from laptops to NASA’s Hubble Telescope.
— The U.S. Department of Energy (DOE) recently announced $26 million in funding geographically and institutionally diverse awardees, including Rensselaer Polytechnic Institute (RPI), who will engage with additional partners and communities to further the conversation around consolidated interim storage of spent nuclear fuel.
Rensselaer Polytechnic Institute’s Steven Cramer, William Weightman Walker Professor of Polymer Engineering, and Todd Przybycien, professor of chemical and biological engineering, will contribute to a three-year research program led by faculty at Massachusetts Institute of Technology (MIT) that aims to design the world’s first fully integrated, continuous mRNA manufacturing platform. Both Cramer and Przybycien are members of Rensselaer’s Shirley Ann Jackson, Ph.D. Center for Biotechnology and Interdisciplinary Studies. The platform is part of an $82 million effort funded by the U.S. Food and Drug Administration (FDA) Center for Biologics Evaluation and Research.
A team of researchers led by Rensselaer Polytechnic Institute’s Jonathan S. Dordick, Ph.D., Institute Professor of Chemical and Biological Engineering, has illuminated a new possibility for the treatment and prevention of COVID-19 in research published in Communications Biology.